Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Modified Xie Bai Decoction is a Traditional Chinese Medicine (TCM) herbal formulation based on the classic Xie Bai San (Drain the White Powder) formula. It is utilized in the treatment of respiratory conditions, specifically chronic cough, by clearing lung heat and relieving cough and asthma. The modification typically involves adjusting the core ingredients—*Morus alba* (Sang Bai Pi), *Lycium chinense* (Di Gu Pi), *Glycyrrhiza uralensis* (Gan Cao), and *Oryza sativa* (Geng Mi)—to better suit the patient's specific syndrome differentiation, such as phlegm-heat or lung deficiency. This specific version is part of the clinical experience of Professor Gao Feng at Wangjing Hospital, China Academy of Chinese Medical Sciences.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on modified Xie Bai Decoction.